NO974603D0 - Anvendelse av imidazo£1,2-a|pyridin-3-acetamidderivater for terapeutisk behandling av neuropsykiatriske syndromer assosiert med disfunksjon av de sentrale områder av de basale ganglia - Google Patents

Anvendelse av imidazo£1,2-a|pyridin-3-acetamidderivater for terapeutisk behandling av neuropsykiatriske syndromer assosiert med disfunksjon av de sentrale områder av de basale ganglia

Info

Publication number
NO974603D0
NO974603D0 NO974603A NO974603A NO974603D0 NO 974603 D0 NO974603 D0 NO 974603D0 NO 974603 A NO974603 A NO 974603A NO 974603 A NO974603 A NO 974603A NO 974603 D0 NO974603 D0 NO 974603D0
Authority
NO
Norway
Prior art keywords
imidazo
dysfunction
therapeutic treatment
basal ganglia
central regions
Prior art date
Application number
NO974603A
Other languages
English (en)
Other versions
NO315408B1 (no
NO974603L (no
Inventor
Elena Benincasa
Original Assignee
Clarendon Trading & Investimen
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Clarendon Trading & Investimen filed Critical Clarendon Trading & Investimen
Publication of NO974603D0 publication Critical patent/NO974603D0/no
Publication of NO974603L publication Critical patent/NO974603L/no
Publication of NO315408B1 publication Critical patent/NO315408B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Psychology (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
NO19974603A 1995-04-07 1997-10-06 Anvendelse av imidazo[1,2-a]pyridin-3-acetamidderivater for terapeutisk behandling av neuropsykiatriske syndromer assosiert med disfunksjonav de sentraleområder av de basale ganglia NO315408B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT95RM000223A IT1276522B1 (it) 1995-04-07 1995-04-07 Uso dello zolpidem per il trattamento terapeudico di sindromi neuropsichiatriche associate a disfunsione e di circuiti neurali dei
PCT/IT1996/000063 WO1996031210A1 (en) 1995-04-07 1996-04-02 USE OF IMIDAZO[1,2-a]PYRIDINE-3-ACETAMIDE DERIVATIVES FOR THE THERAPEUTIC TREATMENT OF NEUROPSYCHIATRIC SYNDROMES ASSOCIATED WITH DISFUNCTION OF THE NEURAL CIRCUITS OF THE BASAL GANGLIA

Publications (3)

Publication Number Publication Date
NO974603D0 true NO974603D0 (no) 1997-10-06
NO974603L NO974603L (no) 1997-11-24
NO315408B1 NO315408B1 (no) 2003-09-01

Family

ID=11403250

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19974603A NO315408B1 (no) 1995-04-07 1997-10-06 Anvendelse av imidazo[1,2-a]pyridin-3-acetamidderivater for terapeutisk behandling av neuropsykiatriske syndromer assosiert med disfunksjonav de sentraleområder av de basale ganglia

Country Status (25)

Country Link
US (1) US5891891A (no)
EP (1) EP0819002B1 (no)
JP (1) JP4049390B2 (no)
KR (1) KR100425628B1 (no)
CN (1) CN1198612C (no)
AR (1) AR003414A1 (no)
AT (1) ATE222763T1 (no)
AU (1) AU707759B2 (no)
CA (1) CA2217590C (no)
CZ (1) CZ292020B6 (no)
DE (1) DE69623271T2 (no)
DK (1) DK0819002T3 (no)
EA (1) EA000396B1 (no)
ES (1) ES2182967T3 (no)
HU (1) HUP9900733A3 (no)
IL (1) IL117824A (no)
IT (1) IT1276522B1 (no)
MX (1) MX9707712A (no)
NO (1) NO315408B1 (no)
NZ (1) NZ304107A (no)
PL (1) PL322647A1 (no)
PT (1) PT819002E (no)
TW (1) TW450816B (no)
WO (1) WO1996031210A1 (no)
ZA (1) ZA962711B (no)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7632517B2 (en) * 1997-10-01 2009-12-15 Novadel Pharma Inc. Buccal, polar and non-polar spray containing zolpidem
US6333345B1 (en) 1999-05-14 2001-12-25 Sepracor, Inc. Methods of using and compositions comprising N-desmethylzolpidem
US6399621B1 (en) 1999-08-10 2002-06-04 American Cyanamid Company N-methyl-N-(3-{3-[2-thienylcarbonyl]-pyrazol-[1, 5-α]-pyrimidin-7-yl}phenyl)acetamide and compositions and methods related thereto
US20030091632A1 (en) * 1999-08-26 2003-05-15 Neurocrine Biosciences, Inc. Controlled-release sedative-hypnotic compositions and methods related thereto
US6485746B1 (en) 2000-08-25 2002-11-26 Neurocrine Biosciences, Inc. Controlled-release sedative-hypnotic compositions and methods related thereto
US6384221B1 (en) 1999-09-02 2002-05-07 Neurocrine Biosciences, Inc. Polymorphs of N-methyl-N-(3-{3-[2-thienylcarbonyl]-pyrazol-[1,5-α]-pyrimidin-7-yl}phenyl)acetamide and compositions and methods related thereto
AU5066101A (en) * 2000-04-13 2001-10-30 Synthon B.V. Modified release formulations containing a hypnotic agent
DE20122435U1 (de) * 2000-04-24 2005-10-06 Teva Pharmaceutical Industries Ltd. Mikronisiertes Zolpidem-Hemitartrat
DE10041478A1 (de) * 2000-08-24 2002-03-14 Sanol Arznei Schwarz Gmbh Neue pharmazeutische Zusammensetzung
DE10117183A1 (de) * 2001-04-05 2002-10-10 Gruenenthal Gmbh Verwendung von substituierten Imidazo[1,2-a]-pyridinverbindungen als Arzneimittel
GB0311457D0 (en) * 2003-05-19 2003-06-25 Sciencom Ltd New therapeutic use
JP2008506630A (ja) * 2003-05-19 2008-03-06 サイエンコム・リミテッド ゾルピデムの更なる治療的使用
DE10334187A1 (de) * 2003-07-26 2005-03-03 Schwarz Pharma Ag Substituierte 2-Aminotetraline zur Behandlung von Depressionen
DE10334188B4 (de) 2003-07-26 2007-07-05 Schwarz Pharma Ag Verwendung von Rotigotin zur Behandlung von Depressionen
PL1691811T3 (pl) 2003-12-11 2014-12-31 Sunovion Pharmaceuticals Inc Skojarzenie leku uspokajającego i modulatora neuroprzekaźnikowego oraz sposoby poprawy jakości snu i leczenia depresji
DE10361258A1 (de) 2003-12-24 2005-07-28 Schwarz Pharma Ag Verwendung von substituierten 2-Aminotetralinen zur vorbeugenden Behandlung von Morbus Parkinson
DE602005018763D1 (de) 2004-02-18 2010-02-25 Sepracor Inc Dopamin-agonisten-kombinationstherapie mit sedativa zur verbesserung der schlafqualität
DE102004014841B4 (de) 2004-03-24 2006-07-06 Schwarz Pharma Ag Verwendung von Rotigotin zur Behandlung und Prävention des Parkinson-Plus-Syndroms
DE602006008339D1 (en) * 2005-11-18 2009-09-17 Synhton B V Zolpidemtabletten
GB2443928A (en) * 2006-11-08 2008-05-21 Regen Therapeutics Plc Transdermal pharmaceutical composition comprising Zolpidem
GB0809936D0 (en) * 2008-05-30 2008-07-09 Regen Therapeutics Plc Therapeutic use of zolpidem
WO2017214442A1 (en) 2016-06-08 2017-12-14 President And Fellows Of Harvard College Methods and compositions for reducing tactile dysfunction and anxiety associated with autism spectrum disorder, rett syndrome, and fragile x syndrome
US11434244B2 (en) 2018-05-29 2022-09-06 President And Fellows Of Harvard College Compositions and methods for reducing tactile dysfunction, anxiety, and social impairment

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2492382A1 (fr) * 1980-10-22 1982-04-23 Synthelabo Derives d'imidazo (1,2-a) pyridine, leur preparation et leur application en therapeutique
US5032595A (en) * 1989-11-24 1991-07-16 Fidia-Georgetown Institute For The Neurosciences Method of stimulating steroidogenesis with alpidem
US5206382A (en) * 1991-06-27 1993-04-27 Fidia Georgetown Institute For The Neurosciences Indole derivatives, pharmaceutical compositions and methods of treating neurological and psychiatric disorders

Also Published As

Publication number Publication date
CA2217590A1 (en) 1996-10-10
AU5120096A (en) 1996-10-23
TW450816B (en) 2001-08-21
CN1183719A (zh) 1998-06-03
DE69623271D1 (de) 2002-10-02
CA2217590C (en) 2008-08-12
IL117824A (en) 2000-08-31
AR003414A1 (es) 1998-08-05
ATE222763T1 (de) 2002-09-15
NZ304107A (en) 2000-12-22
NO315408B1 (no) 2003-09-01
HUP9900733A2 (hu) 1999-07-28
ITRM950223A0 (it) 1995-04-07
EP0819002B1 (en) 2002-08-28
DK0819002T3 (da) 2003-01-06
IT1276522B1 (it) 1997-10-31
DE69623271T2 (de) 2003-07-24
WO1996031210A1 (en) 1996-10-10
EA000396B1 (ru) 1999-06-24
ZA962711B (en) 1996-07-30
HUP9900733A3 (en) 2003-05-28
JP4049390B2 (ja) 2008-02-20
IL117824A0 (en) 1996-08-04
ES2182967T3 (es) 2003-03-16
KR19980703707A (ko) 1998-12-05
KR100425628B1 (ko) 2004-06-23
PT819002E (pt) 2003-01-31
EA199700308A1 (ru) 1998-04-30
US5891891A (en) 1999-04-06
MX9707712A (es) 1998-03-31
NO974603L (no) 1997-11-24
CZ292020B6 (cs) 2003-07-16
CZ316797A3 (cs) 1998-05-13
AU707759B2 (en) 1999-07-22
PL322647A1 (en) 1998-02-16
ITRM950223A1 (it) 1996-10-07
CN1198612C (zh) 2005-04-27
EP0819002A1 (en) 1998-01-21
JPH11503149A (ja) 1999-03-23

Similar Documents

Publication Publication Date Title
NO974603L (no) Anvendelse av imidazo£1,2-a|pyridin-3-acetamidderivater for terapeutisk behandling av neuropsykiatriske syndromer assosiert med disfunksjon av de sentrale områder av de basale ganglia
FI813288L (fi) Derivat av imidazo/1,2-a/pyridin deras framstaellning och anvaendning vid behandling av sjukdomar
HU9401317D0 (en) Antiviral 2-ethyl - 1h imidazo (4,5-c) quinolin-4-amines
NO305886B1 (no) Anvendelse av et organisk nitritt for fremstilling av medikamenter for kontinuerlig, vasodilatorisk terapi
ZA897699B (en) Pyrrolo(1,2-a)imidazole and imidazo(1,2-a)pyridine derivatives and their use as 5-lipoxygenase pathway inhibitors
FI894169A (fi) Menetelmä valmistaa farmakologisesti arvokasta pyrrolo/3,2,1-jk//1,4/bentsodiatsepiinijohdannaista
NO20013645D0 (no) Anvendelse av pyridazino[4,5-b]indol-1-acetamid-derivater for fremstilling av medisiner for behandling av sykdommer relatert tildysfunksjonen av perifere benzodiazepinreseptorer
BG95241A (bg) Метод за получаване на 2,9-дизаместени-4н-пиридо/1.2-а/ пиримидин-4-они
HUP9901258A3 (en) Imidazo[2,1-b]thiazole and thiazolo[3,2-a]pyrimidine derivatives, process for the preparation thereof, their use and pharmaceutical compositions containing them
FI801515A (fi) Foerfarande foer framstaellning av 3-substituerade tetrahydropyrrolo /1,2-a/ pyrimidiner farmaceutiska preparat innehaollande dessa foereningar samt de nya 3-substituerade tetrahydro-pyrrolo /1,2-a/ pyrimidinerna
FI98816B (fi) Menetelmä uusien terapeuttisesti käyttökelpoisten 4,5,6,7-tetrahydroimidatso [4,5,1-jk][1,4]bentsodiatsepin-2-oni ja -2-tionijohdannaisten valmistamiseksi
NO932783D0 (no) Fremgangsmaate for fremstilling av imidazopyridiner
FI912247A (fi) Menetelmä terapeuttisesti käyttökelpoisten pyrrolo/2,3-b/indoliketonijohdannaisten valmistamiseksi
FI93839B (fi) Menetelmä uusien terapeuttisesti käyttökelpoisten 2,3-dihydroksi-pyratsino/2,3-f/kinoksaliini- ja pyratsino/2,3-g//1,5/bentsodiatsepiinijohdannaisten valmistamiseksi
FI943706A (fi) Menetelmä kiraalisen etyyli-(5-amino-1,2-dihydro-2-metyyli-3-fenyylipyrido(3,4-b)pyratsin-7-yyli)karbamaatin valmistamiseksi
NO166128C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive imidazo(1,2-a)pyridinderivater.
ZA893606B (en) Use of diazepinones for treating disorders of the microcirculation
FI962714A0 (fi) Menetelmä terapeuttisesti käyttökelpoisten naftyridiinijohdannaisten valmistamiseksi
FI925310A0 (fi) Menetelmä uusien terapeuttisesti käyttökelpoisten 4-okso-4,5-dihydro-imidatso/1,5-a/pyrido/2,3-e/pyratsiinijohdannaisten valmistamiseksi
NO177786B (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive pyrido-[2,3-bÅ-benzazepin- (og -tiazepin)-5(6H)-on-derivater
FI951043A (fi) Menetelmä lääkeaineina käyttökelpoisten (1,2,3,10,14b-heksahydropyratsino(1,2-a)pyrrolo(2,1-c)(1,4)bentsatsepin-2-yyli)alkaanihappojen valmistamiseksi
ZA886511B (en) Pyrrolo(1,2-a)imidazole and imidazo(1,2-a)pyridine derivatives and their use as 5-lipoxygenase pathway inhibitors
PT73145A (en) Process for the preparation of 7,8,9,10-tetrahydrofuro/3,2-e/pyrido/4,3-b/indole derivatives having efect on the central nervous system and their application in the preparation of pharmaceutical compositions having effect on the central nervous system

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees